Clinical Trial Update: Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study exploring a neuroleptic-sparing strategy for managing agitated delirium using neuroleptics in combi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Epilepsy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Delirium, Epileptics | Phase 2, Phase 3 | Status: RECRUITING